Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Upstream Bio Appoints Stacy Price as Chief Technology Officer
-
Mirion Technologies Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2030
-
Explorance World 2025 Reveals Full Program in Montreal
-
Viking Reports First Quarter 2025 Financial Results
-
Freightos Reports First Quarter 2025 Results
-
IXS Launches World First “BTC Real Yield”
-
Bridging the Retirement Gap: Global Atlantic Survey Unveils Surprising Differences in Priorities Between Financial Advisors and Their Clients
-
Angeles Equity Partners Portfolio Company O’Hara’s Son Roofing Acquires Starkweather
-
Rockwell Automation Launches EtherNet/IP In-cabinet Solution to Help Manufacturers Build Smarter, More Efficient Panels
-
D-Wave Announces General Availability of Advantage2 Quantum Computer, Its Most Advanced and Performant System
-
PROPWR Secures 10-Year Contract for 80 Megawatts of Power Capacity
-
Keeper Security Appoints Shane Barney as Chief Information Security Officer
-
Viridian Therapeutics Announces Positive Long-Term Durability Data from the Veligrotug Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease (TED)
-
iFIT Inc. Enters Connected Pilates with Acquisition of Reform RX
-
Eltek Ltd. Reports 2025 First Quarter Financial Results
-
Relation Insurance Services Acquires Engle and Associates Insurance Brokers
-
I-Mab to Present at Jefferies Global Healthcare Conference
-
KKR Releases “The Art of Learning”
-
Almonty Joins DARPA Funded Critical Minerals Forum
-
Soda Is Fizzling Out: Why the Performance Generation Prefers Function Over Fizz
-
Latus Bio Announces Publication of Breakthrough Research on Novel AAV Capsid Variant for Huntington’s and Parkinson’s Disease Gene Therapy
-
Leading Change Together: HR Tech 2025 Reveals Initial Agenda
-
Early Warning Labs CEO Highlights Earthquake Resilience at UNDRR & ARISE Forum in Honduras
-
Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant
-
Outpost24 Introduces AI-Powered Digital Risk Protection to Simplify and Expedite Threat Analysis
-
Boomerang Launches Meeting Poll, the Cleanest Way to Schedule Group Meetings
-
PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer
-
Arbe Announces Q1 2025 Financial Results
-
United Natural Foods to Release Fiscal 2025 Third Quarter Results on June 10, 2025
-
Summit Health Announces Internalization of Genomic Testing Cooperative State-of-The-Art Next Generation Sequencing DNA and RNA Profiling Tests for Tissue and Liquid Biopsy of Solid Tumors and Hematolo
-
Domini Shareholder Proposal on Biodiversity Set to Go to Vote at Home Depot
-
Covalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing Opportunities
-
Travel Priorities Reinvented: Expedia Group’s 2025 Traveler Value Index Signals a Shift in Consumer Priorities
-
/R E P E A T -- PAN GLOBAL INTERSECTS 1.08 G/T GOLD OVER 46 METERS FROM NEAR SURFACE IN FIRST DRILLHOLE AT CÁRMENES PROJECT, SPAIN/
-
Gatik Establishes Safety Advisory Council, Taps Former US Department of Transportation Leadership and Executives From Trucking and Automotive Industries to Guide Safety Strategy
-
PharmaEssentia to Present Phase 3 SURPASS-ET Data in Oral Session at 2025 ASCO Annual Meeting
-
ReposiTrak Adds 40 Seafood Suppliers to the Queue for the Rapidly Expanding Food Traceability Network
-
Mobilicom and ARK Electronics Partner to Develop and Launch Cybersecure Solutions for Mass-Market Drone and Robotics Platforms
-
Plug Power’s GenEco Electrolyzers Power Live Customer Demos at The Green Box Innovation Hub
-
ASP Isotopes Inc. Announces an Agreement Relating to the Potential Acquisition of Renergen Limited Expected to Create a Global Critical Materials Company
-
atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression
-
Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting
-
OTC Markets Group Welcomes Currency Exchange International Corp. to the OTCQX
-
Amplify ETFs Launches the Amplify Samsung U.S. Natural Gas Infrastructure ETF (USNG)
-
NANO Nuclear and MIT’s Department of Nuclear Science and Engineering Launch Advanced Irradiation Study to Investigate Salt-Based Thermal Storage for Nuclear Applications
-
Toolstation Selects GXO as its Logistics Partner in the Netherlands
-
Veriff Named a Leader in G2’s Spring 2025 Grid® Report
-
PolyPid to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BAKKAVOR GROUP PLC - Ordinary Shares
-
Beckley Psytech announces positive topline data from Part 2 of its Phase IIa study of BPL-003 (intranasal 5-MeO-DMT benzoate) in combination with SSRIs for treatment resistant depression

